Global Liver Fibrosis Clinical Trials Review Market | Page 3

Mar 12, 2015: Galectin Therapeutics Engages PPD to Conduct GR-MD-02 Phase 2 Trial in NASH,
Submits Special Protocol Assessment to FDA 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Merck & Co., Inc. 34
Clinical Trial Overview of Merck & Co., Inc. 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Gilead Sciences, Inc. 37
Clinical Trial Overview of Gilead Sciences, Inc. 37
Read Complete Report with TOC @ http://www.radiantinsights.com/research/liver-fibrosisglobal-clinical-trials-review-h1-2015
Nitto Denko Corporation 38
Clinical Trial Overview of Nitto Denko Corporation 38
Galectin Therapeutics, Inc. 39
Clinical Trial Overview of Galectin Therapeutics, Inc. 39
C. H. Boehringer Sohn AG & Co. KG 40
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 40
FibroGen, Inc. 41
Clinical Trial Overview of FibroGen, Inc. 41
Conatus Pharmaceuticals Inc. 42
Clinical Trial Overview of Conatus Pharmaceuticals Inc. 42
Astellas Pharma Inc. 43
Clinical Trial Overview of Astellas Pharma Inc. 43
Clinical Trial Overview of Top Institutes / Government 44
Imperial College London 44
Clinical Trial Overview of Imperial College London 44